Segment-Specific c-erbb2 Expression in Human Autosomal Recessive Polycystic Kidney Disease
|
|
- William Carr
- 5 years ago
- Views:
Transcription
1 J Am Soc Nephrol 12: , 2001 Segment-Specific c-erbb2 Expression in Human Autosomal Recessive Polycystic Kidney Disease KOICHI NAKANISHI, WILLIAM E. SWEENEY, JR., and ELLIS D. AVNER Rainbow Center for Childhood PKD, Department of Pediatrics, Rainbow Babies and Children s Hospital and Case Western Reserve University, Cleveland, Ohio. Abstract. c-erbb2 (also referred to as Neu or HER2), a transmembrane glycoprotein with intrinsic tyrosine kinase activity, is structurally related to epidermal growth factor receptor (EGFR) and forms active heterodimers with EGFR as well as other members of the EGFR family. c-erbb2 is reported to mediate differentiation and proliferation in epithelial cells and is expressed in a tissue-specific and developmental stage specific manner. Given the role of EGFR in cystic renal epithelial hyperplasia and the immature phenotype of cystic renal epithelial cells, the segment-specific expression pattern of c- ErbB2 in human autosomal recessive polycystic kidney disease (ARPKD) was examined in nine ARPKD kidney specimens ranging from gestational age 17 wk through postnatal age 4 wk. c-erbb2 staining of human ARPKD samples showed increased expression with increasing gestational age compared with normal human fetal and postnatal kidneys. This increased c-erbb2 expression was primarily localized to the apical surfaces of cystic collecting tubule cells, similar to the pattern of EGFR expression, and paralleled collecting tubular cyst formation and growth. Autosomal recessive polycystic kidney disease (ARPKD) is invariably characterized by the formation and enlargement of renal collecting tubular cysts as well as hepatic biliary ectasia and fibrosis (1,2). Extensive morphologic analysis and mathematical modeling of cyst formation and growth indicate that epithelial hyperplasia is a necessary element in the formation and growth of cystic lesions in polycystic kidney disease (PKD) (1). Evidence from a number of laboratories has established a role for the epidermal growth factor (EGF)-transforming growth factor- (TGF- )-epidermal growth factor receptor (EGFR) axis in promoting epithelial hyperplasia and collecting tubular cyst enlargement in PKD (3). These studies demonstrate that EGFR is overexpressed and mislocated to the apical surface of cystic tubular epithelium in human ARPKD, in human autosomal-dominant PKD (ADPKD), and in murine models of ARPKD (cpk, bpk, and orpk) and ADPKD (4 8). Furthermore, in murine ARPKD, inhibition of EGFR tyrosine kinase through genetic or pharmacologic manipulation drastically reduces cyst formation and growth (5,9). The c-erbb2 oncogene (also referred to as neu or HER2) encodes a 185-kD transmembrane glycoprotein with intrinsic tyrosine kinase activity. The c-erbb2 protein is structurally related to EGFR and is able to form active heterodimers with EGFR (10,11). c-erbb2 is commonly expressed in fetal epithelial cells of the human kidney and to a lesser degree in normal human adult kidneys (12,13). Amplification of c-erbb2 Received February 14, Accepted June 14, Correspondence to Dr. Ellis D. Avner, Department of Pediatrics, Rainbow Babies and Children s Hospital, Euclid Avenue, LC 6003, Cleveland, OH Phone: ; Fax: ; eda@po.cwru.edu / Journal of the American Society of Nephrology Copyright 2001 by the American Society of Nephrology has been demonstrated in human breast, ovarian, and pancreatic carcinoma, and some studies have suggested that c-erbb2 amplification may have significant prognostic implications (14 19). These findings suggest that c-erbb2 plays a role in both normal proliferation and neoplastic transformation of epithelial cells. Given these data, as well as the established role of EGFR in cystic renal epithelial hyperplasia, we sought to examine the segment-specific expression pattern of c-erbb2 in fetal and infantile human ARPKD. The results demonstrate segment-specific and cyst formation/growth-related c-erbb2 expression in human ARPKD. These data suggest a potential role for c-erbb2 in proximal tubular cyst formation and, in concert with EGFR, in progressive collecting tubular cyst formation and enlargement in ARPKD. Materials and Methods Specimens: ARPKD Diagnosis We examined nine human renal ARPKD specimens ranging from gestational age 17 wk (GA17) to postnatal age 4 wk (PA4) from seven families (1 GA17, 2 GA22, 1 GA23, 1 GA26, 1 GA29, 1 GA33, 1 GA34, and 1 PA4). ARPKD was diagnosed in all cases by consensus clinical, radiographic, and genetic criteria (20). Five normal kidney specimens aged GA12, GA13, GA14, GA15, PA4, and PA16 were received as formalin-fixed, paraffin-embedded blocks and used as controls. Immunohistochemistry Sections were incubated for 1 h at room temperature with anti c- ErbB2 antibody (A485, affinity-purified rabbit polyclonal, 1:100; DAKO, Carpinteria, CA), and serial sections were incubated for 1 h at room temperature with anti-egfr (mouse monoclonal clone 29.1, 1:200; Sigma Chemical Co., St. Louis, MO) and lectins. Cyst localization was examined using our previously described segment-specific lectin binding method with biotin-labeled Lotus Tetragonolobus
2 380 Journal of the American Society of Nephrology J Am Soc Nephrol 12: , 2001 (Sigma) as a marker for proximal tubules (PT; visualized with Fast Red) and biotin-labeled Arachis Hypogaea (Sigma) as a marker for collecting tubules (CT; visualized with DAB) (4,5,7,9,21 24). Staining was scored semiquantitatively with the use of computer video image analysis as follows: 0, absent; 1 to 3, weak; 4 to 7, moderate; and 8 to 10, strong. Results c-erbb2 and EGFR Expression in Normal Human Fetal and Postnatal Kidneys In normal kidneys GA12, GA13, GA14, GA15, PA4, and PA16, PT demonstrated weak cytoplasmic expression of c- ErbB2 and CT demonstrated moderate basolateral as well as apical expression of c-erbb2 (Table 1, Figure 1, A and C). In normal kidneys, c-erbb2 expression was greater in CT than in PT, and expression in all segments decreased with increasing gestational age (Figure 1, A and C). EGFR expression in normal fetal kidney specimens demonstrated apical as well as basolateral EGFR expression in CT (Figure 1B). However, by PA4, EGFR expression was restricted to the basolateral membrane domain in all tubular segments (Figure 1D). The postnatal expression pattern of c-erbb2 remained apical as well as basolateral in CT and primarily cytoplasmic in PT (Figure 1C). The intensity, however, was markedly decreased when compared with fetal specimens, suggesting a temporal decrease in c-erbb2 expression. Proximal Tubule: c-erbb2 and EGFR Expression in Human ARPKD At GA17, both noncystic and cystic PT demonstrated cytoplasmic expression of c-erbb2 (Figure 2B, Table 1). However, expression of c-erbb2 was greater in cystic compared with noncystic PT (Figure 2B). c-erbb2 expression in cystic PT decreased with advancing gestational age, paralleling decreasing proximal tubular cyst numbers and decreasing PT cyst size (Table 1, Figure 3) (22). The difference in c-erbb2 expression level between cystic PT and noncystic PT decreased with advancing gestational age. All ARPKD and normal specimens demonstrated cystoplastic and basolateral EGFR staining in PT (Figure 2, C and F). Collecting Tubule: c-erbb2 and EGFR Expression in Human ARPKD At GA17, both noncystic and cystic CT demonstrated basolateral and apical expression of c-erbb2 in equal intensity (Figure 2B, Table 1). In contrast to decreasing CT expression with increasing age in normal specimens, c-erbb2 expression in cystic CT showed little decline with advancing gestational age, particularly on the apical cell surface of cystic CT (Figure 2, B insert and E insert). This increased c-erbb2 expression in cystic CT paralleled collecting tubular cyst formation and growth, as well as increased apical EGFR expression in cystic CT (Table 1, Figures 2, E and F, and 3). c-erbb2 expression in noncystic CT was less intense than in cystic CT and decreased with advancing gestational age similar to that seen in normal fetal specimens (Figure 2, B and E, Table 1). At GA33, expression of c-erbb2 in noncystic CT was weak and the difference of c-erbb2 expression between cystic and noncystic CT was striking. At PA4, the expression level of c-erbb2 in cystic CT began to decline slightly, whereas expression level of apical EGFR remained high in cystic CT (Table 1, Figure 2, Table 1. Segment-specific developmental expression of c-erbb2 and EGFR a Segment c-erbb2 Expression EGFR Expression Normal fetal kidneys PT CT ARPKD specimens PT (cystic) PT (noncystic) CT (cystic) CT (noncystic) Weak cytoplasmic staining that decreased with increasing gestational age Moderate BL and AP staining that decreased with increasing gestational age Moderate to strong cytoplasmic staining that decreased with increasing age; decreased expression paralleled decreasing PT cysts Weak cytoplasmic staining that decreased with increasing gestational age Moderate to strong BL and AP expression that remained strong in intensity, especially on the apical surface with increasing gestational age; increased expression paralleled increasing CT cyst formation and growth Moderate BL and AP staining that decreased with increasing gestational age Moderate cytoplasmic and BL staining Moderate BL and AP staining restricted to BL by GA23 Moderate BL staining Moderate BL staining Strong BL and strong AP expression that increased in intensity, especially on the apical surface with increasing gestational age; increased expression paralleled increasing CT cyst formation and growth Moderate BL and AP staining restricted to BL by GA23 a EGFR, epidermal growth factor receptor; ARPKD, autosomal recessive polycystic kidney disease; PT, proximal tubule; CT, collecting tubule; BL, basolateral; AP, apical.
3 J Am Soc Nephrol 12: , 2001 c-erbb2 in human ARPKD 381 Figure 1. Immunoperoxidase staining of c-erbb2 (A) and epidermal growth factor receptor (EGFR) (B) in gestational age 13 wk (GA13) normal fetal kidney and c-erbb2 (C) and EGFR (D) in postnatal age 4 wk (PA4) normal human kidney. Expression level of c-erbb2 in normal proximal tubules (PT) is weak and cytoplasmic (A) and decreases with increasing gestational age (C). EGFR expression is moderate throughout gestation but becomes localized to the basolateral membrane domain by PA4 (D). In normal collecting tubules (CT), c-erbb2 is consistently higher, at any given age, than c-erbb2 expression in normal PT (A). c-erbb2 expression in normal CT declines with increasing gestational age and remains apical and basolateral (C). EGFR expression in normal fetal kidney specimens demonstrated apical as well as basolateral EGFR expression in CT at GA13 (B). However, by PA4, EGFR expression was restricted to the basolateral membrane domain in all tubular segments (D). In normal kidneys, c-erbb2 expression was greater in CT than in PT, and expression in all segments decreased with increasing gestational age, suggesting a temporal decrease in c-erbb2 expression. Magnifications: 800 in A and B; 2000 in C and D. E insert and F insert). All ARPKD specimens demonstrated apical as well as basolateral expression of EGFR in cystic CT (Figure 2F and insert). This apical expression of EGFR in CT was limited to cystic tubules except in kidneys at GA13, GA17, and GA22 that had apical EGFR expression in noncystic CT (Figure 1B, Table 1). Discussion Human ARPKD has been classically described as a cystic kidney disease in which lesions are localized to CT (1). However, studies of the ontogeny of cyst formation in murine models of ARPKD have demonstrated two distinct phases in cystic nephron involvement (4,7,23 25). Recently, we established that human ARPKD, like murine ARPKD, has a transient phase of proximal tubular cyst formation during fetal development (22). Given the role of c-erbb2 and EGFR in mediating proliferation and differentiation in renal epithelium (12,13,21,26,27), we examined segment-specific c-erbb2 and EGFR expression in normal and ARPKD human fetal kidneys. In agreement with previous studies, all five normal kidney specimens in the current study demonstrated weaker c-erbb2 expression in PT compared with CT (12). However, in human fetal ARPKD kidneys at GA17, c-erbb2 expression in cystic
4 382 Journal of the American Society of Nephrology J Am Soc Nephrol 12: , 2001 Figure 2. Lectin staining of GA17 (A) and PA4 (D) human autosomal recessive polycystic kidney disease (ARPKD) kidney (red [Lotus Tetragonolobus] PT, brown [Arachis Hypogaea] CT). Immunoperoxidase staining of c-erbb2 (B) and EGFR (C) in GA17 human ARPKD kidney and c-erbb2 (E) and EGFR (F) in PA4 human ARPKD kidney. Inserts show high-power c-erbb2 staining of CT cysts in GA17 (B) and PA4 (E) ARPKD kidney and EGFR staining of CT cysts in GA17 (C) and PA4 (F) ARPKD kidney. Photographs show that in human fetal ARPKD kidneys at GA17, c-erbb2 expression in cystic PT was equivalent to that in cystic CT and was more intense than that in noncystic PT (B). At GA17, both noncystic and cystic CT demonstrated basolateral and apical expression of c-erbb2 (B) in equal intensity. c-erbb2 expression in cystic CT showed little decline with advancing gestational age, particularly on the apical cell surface of cystic CT (insert, B and E). In cystic CT, EGFR expression is strong throughout gestation and remains apically and basolaterally expressed (F and insert) in contrast to normal CT.
5 J Am Soc Nephrol 12: , 2001 c-erbb2 in human ARPKD 383 Figure 3. c-erbb2 staining in cystic PT and cystic CT versus the ratio of the number of CT cysts to PT cysts. Data demonstrate that as the expression of c-erbb2 declines in cystic PT, the ratio of CT/PT cysts increases, indicating that the number of PT cysts declines and/or the number of CT cysts increases. In addition, in cystic CT, the expression of c-erbb2 remains strong throughout gestation (unlike normal CT) and the number of CT cysts increases. This increase in CT cysts parallels strong c-erbb2 expression in cystic CT. PT was equivalent to that in cystic CT and was more intense than that in noncystic PT. The expression level in cystic PT after GA17 decreased with advancing gestational age, paralleling decreases in PT cyst formation and enlargement (22). These findings suggest that c-erbb2 may be involved in the developmentally regulated pathophysiology of PT cyst formation in ARPKD. The contribution of cystic PT to the total population of kidney cysts decreases during disease progression. This is most likely due to restriction of proximal tubular cystogenesis to a specific developmental stage in the context of ongoing nephrogenesis and progressive formation of collecting tubular cysts (25). The shift in nephron involvement during renal organogenesis suggests that there may be a developmentally regulated pattern of cystic gene expression or tubular responsiveness to cyst-promoting processes. Regulation of PT c-erbb2 expression may be one factor involved in this process. In cystic CT from human fetal ARPKD kidney specimens, c-erbb2 expression remained strong with advancing gestational age, particularly on the apical cell surface. This increased c-erbb2 expression in CT paralleled collecting tubular cyst formation and growth as well as apical EGFR expression in cystic CT lesions. In contrast, c-erbb2 expression in noncystic CT decreased with advancing gestational age. However, at PA4, expression level of c-erbb2 in cystic CT began to decrease, whereas expression level of apical EGFR remained high. These findings suggest that c-erbb2 may also be involved, in a developmentally regulated manner, in the pathophysiology of early to mid-ct cyst formation. Herrera (28) reported c- ErbB2 amplification in ADPKD (3 of 3 specimens) but not ARPKD specimens (0 of 3 specimens). Ages of ARPKD specimens were not described in that report, and differences between those and the current findings may relate to stage or severity of the cystic lesions and/or ages of the specimens. EGFR is overexpressed and mislocated to the apical surface of cystic tubular epithelium in human ARPKD and ADPKD and in the murine models of ARPKD (cpk, bpk, and orpk) and ADPKD (3 8). In this study, we report apical EGFR expression in noncystic CT in specimens at GA17 and GA22 and in four normal human fetal kidney specimens aged between GA12 and GA15 as well as in cystic CT in all ARPKD kidney specimens regardless of age. Apical EGFR expression in noncystic CT is not seen in human ARPKD older than GA22. As previously reported, apical EGFR expression may be a normal pattern in CT of developing human kidneys (3,6). These findings confirm that cystic renal CT demonstrates features of an immature epithelial phenotype (29,30). In summary, developmental expression patterns of c-erbb2 suggest a potential role for this glycoprotein in proximal tubular cyst formation and enlargement and in concert with EGFR, in progressive collecting tubular cyst formation and enlargement in ARPKD. These findings suggest that c-erbb2, like EGFR, may be a potential target for cyst reduction therapy in ARPKD. Acknowledgments We thank Dr. Lisa M. Guay-Woodford of the University of Alabama Birmingham; Dr. Klaus Zerres of Institute for Human Genetics, Technical University of Aachen, Germany, for providing some of the ARPKD specimens; and Dr. Yasuhiro Iwai of the Department of Pathology, Takatsuki General Hospital, Japan, Dr. Norishige Yoshikawa, Professor of Health Sciences, Kobe University School of Medicine, Kobe, Japan, and Dr. Cynthia G. Goodyer, Montreal Children s Hospital for providing normal human fetal kidney specimens. This study was supported by funding from the Polycystic Kidney Research Foundation and the National Institute of Diabetes, Digestive and Kidney Diseases Grant DK References 1. McDonald RA, Watkins SL, Avner ED: Polycystic kidney disease. In: Pediatric Nephrology, 4th Ed., edited by Barratt TM, Avner ED, Harmon WE, Baltimore, Lippincott Williams & Wilkins, 1999, pp Kaplan BS, Fay J, Shah V, Dillon MJ, Barratt TM: Autosomal recessive polycystic kidney disease. Pediatr Nephrol 3: 43 49, Murcia NS, Sweeney WE Jr, Avner ED: New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int 55: , Orellana SA, Sweeney WE, Neff CD, Avner ED: Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int 47: , Richards WG, Sweeney WE, Yoder BK, Wilkinson JE, Woychik RP, Avner ED: Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J Clin Invest 101: , Wilson PD, Du J, Norman JT: Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur J Cell Biol 61: 31 42, 1993
6 384 Journal of the American Society of Nephrology J Am Soc Nephrol 12: , Sweeney WE Jr, Avner ED: Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am J Physiol 275: F387 F394, Lu W, Fan X, Basora N, Babakhanlou H, Law T, Rifai N, Harris PC, Perez-Atayde AR, Rennke HG, Zhou J: Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet 21: , Sweeney WE Jr, Chen Y, Nakanishi K, Frost P, Avner ED: Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int 57: 33 40, Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang- Feng T, Francke V, Ullrich A, Coussens L: The neu gene: An erbb-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229: , King CR, Borrello I, Bellot F, Comoglio P, Schlessinger J: EGF binding to its receptor triggers a rapid tyrosine phosphorylation of the erbb-2 protein in the mammary tumor cell line SK-BR-3. EMBO J 7: , Mori S, Akiyama T, Yamada Y, Morishita Y, Sugawara I, Toyoshima K, Yamamoto T: C-erbB-2 gene product, a membrane protein commonly expressed on human fetal epithelial cells. Lab Invest 61: 93 97, Press MF, Cordon CC, Slamon DJ: Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5: , King CR, Kraus MH, Aaronson SA: Amplification of a novel v-erbb-related gene in a human mammary carcinoma. Science 229: , Venter DJ, Tuzi NL, Kumar S, Gullick WJ: Overexpression of the c-erb B-2 oncoprotein in human breast carcinomas: Immunohistological assessment correlates with gene amplification. Lancet 2: 69 72, Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: , Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: , Wright C, Angus B, Nicholson S, Sainsbury JR, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CH: Expression of c-erbb-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res 49: , Williams TM, Weiner DB, Greene MI, Maguire HJ: Expression of c-erb B-2 in human pancreatic adenocarcinomas. Pathobiology 59: 46 52, Zerres K, Mücher G, Becker J, Steinkamm C, Rudnik- Schöneborn S, Heikkilä P, Rapola J, Salonen R, Germino GG, Onuchic L, Somlo S, Avner ED, Harman LA, Stockwin JM, Guay-Woodford LM: Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): Molecular genetics, clinical experience, and fetal morphology. Am J Med Genet 76: , Avner ED, Sweeney WE Jr: Polypeptide growth factors in metanephric growth and segmental nephron differentiation. Pediatr Nephrol 4: , Nakanishi K, Sweeney WE Jr, Zerres K, Guay-Woodford LM, Avner ED: Proximal tubular cysts in fetal human autosomal recessive polycystic kidney disease. J Am Soc Nephrol 11: , Moyer JH, Lee-Tischler MJ, Kwon HK, Schrick JJ, Avner ED, Sweeney WE, Godfrey VL, Cacheiro NLA, Wilkinson JE, Woychik RP: Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 264: , Nauta J, Ozawa Y, Sweeney WE, Rutledge JC, Avner ED: Renal and biliary abnormalities in a new murine model of recessive polycystic kidney disease. Pediatr Nephrol 7: , Avner ED, Studnicki FM, Young MC, Sweeney WE, Piesco NP, Ellis D, Fetterman GH: Congenital murine polycystic disease: 1. The ontogeny of tubular cyst formation. Pediatr Nephrol 1: , Kokai Y, Cohen JA, Drebin JA, Greene MI: Stage- and tissuespecific expression of the neu oncogene in rat development. Proc Natl Acad Sci USA 84: , Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y: Isolation of the neu/her-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69: , Herrera GA: C-erb B-2 amplification in cystic renal disease. Kidney Int 40: , Cowley BD, Chadwick LF, Granthem JJ, Calvet JP: Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. J Am Soc Nephrol 1: , Grantham JJ: The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: Recent advances. Am J Kidney Dis 28: , 1996
Cellular pathophysiology of cystic kidney disease: insight into future therapies
Int. J. Dev. Biol. 43: 457-461 (1999) Cellular pathophysiology of cystic kidney desease 457 Cellular pathophysiology of cystic kidney disease: insight into future therapies ELLIS D. AVNER*, RICHARD P.
More informationTreatment of polycystic kidney disease with a novel tyrosine kinase inhibitor 1
Kidney International, Vol. 57 (2000), pp. 33 40 Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor 1 WILLIAM E. SWEENEY JR, YUEGANG CHEN, KOICHI NAKANISHI, PHILIP FROST, and
More informationC-erb B-2 amplification in cystic renal disease
Kidney nternational, Vol. 40 (1991), PP. 509 5 13 C-erb B-2 amplification in cystic renal disease GULLERMO A. HERRERA Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi,
More informationIn vitro modulation of cyst formation by a novel tyrosine kinase inhibitor
Kidney International, Vol. 56 (1999), pp. 406 413 GENETIC DISORDERS DEVELOPMENT In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor WILLIAM E. SWEENEY, LIDIA FUTEY, PHILLIP FROST,
More informationTITLE: HER2/neu Antisense Therapeutics in Human Breast Cancer. CONTRACTING ORGANIZATION: Washington University School of Medicine St.
AD Award Number: DAMD17-99-1-9436 TITLE: HER2/neu Antisense Therapeutics in Human Breast Cancer PRINCIPAL INVESTIGATOR: Jeffrey A. Drebin, M.D., Ph.D. CONTRACTING ORGANIZATION: Washington University School
More informationCystic Renal Disease, for USMLE Step One. Howard J. Sachs, MD
Cystic Renal Disease, for USMLE Step One Howard J. Sachs, MD www.12daysinmarch.com The Major Players Medullary Sponge Kidney (MSK) Polycystic Kidney Disease (PKD) Autosomal Recessive: Childhood Autosomal
More informationRole of CFTR in Autosomal Recessive Polycystic Kidney Disease
Role of CFTR in Autosomal Recessive Polycystic Kidney Disease J Am Soc Nephrol 12: 719 725, 2001 KOICHI NAKANISHI, WILLIAM E. SWEENEY, JR., KATHERINE MACRAE DELL, CALVIN U. COTTON, and ELLIS D. AVNER Rainbow
More informationc-erbb-2 overexpression and histologlical type of in situ and invasive breast carcinoma
16 J Clin Pathol 1992;45:16-20 Department of Histopathology, Belfast City Hospital, Lisburn Road, Belfast BT9 7AD J E Somerville L A Clarke J D Biggart Correspondence to: Dr J Somerville Accepted for publication
More informationEGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats
Kidney International, Vol. 64 (2003), pp. 1573 1579 EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats VICENTE E. TORRES, WILLIAM E. SWEENEY, JR., XIAOFANG WANG,
More informationc-erbb-2 expression in benign and malignant breast disease
Br. J. Cancer (1988), 58, 453-457 Be8 The Macmillan Press Ltd., 1988 c-erbb-2 expression in benign and malignant breast disease B.A. Gusterson1, L.G. Machin2, W.J. Gullick3, N.M. Gibbs4, T.J. Powles5,
More informationClinical and Pathologic Findings in Two New Allelic Murine Models of Polycystic Kidney Disease
J Am Soc Nephrol 10: 2534 2539, 1999 Clinical and Pathologic Findings in Two New Allelic Murine Models of Polycystic Kidney Disease CAROLE VOGLER,* SHARON HOMAN, ALETHA PUNG, CONSTANCE THORPE,* JANE BARKER,
More informationDevelopment of Autosomal Recessive Polycystic Kidney Disease in BALB/c-cpk/cpk Mice
J Am Soc Nephrol 11: 1837 1847, 2000 Development of Autosomal Recessive Polycystic Kidney Disease in BALB/c-cpk/cpk Mice JUSTIN L. RICKER,* VINCENT H. GATTONE II,* JAMES P. CALVET, and CAROLYN A. RANKIN
More informationKidney Disease Research
Thomas Weimbs Assistant Professor, Department of Molecular, Cellular & Developmental Biology Kidney Disease Research The mtor pathway is regulated by polycystin 1, and its inhibition reverses renal cystogenesis
More informationShuma Hirashio 1,2, Shigehiro Doi 1 and Takao Masaki 1*
Hirashio et al. Renal Replacement Therapy (2018) 4:24 https://doi.org/10.1186/s41100-018-0164-9 CASE REPORT Open Access Magnetic resonance imaging is effective for evaluating the therapeutic effect of
More informationc-erbb-2 oncoprotein expression in primary and advanced breast cancer
Br. J. Cancer (1991), 63, 439-443 Br. J. Cancer (1991), 63, 439 443 Macmillan 17" Macmillan Press Ltd., 1991 c-erbb-2 oncoprotein expression in primary and advanced breast cancer C. Lovekin', I.O. Ellis',
More informationHER2/neu Amplification in Breast Cancer Stratification by Tumor Type and Grade
Anatomic Pathology / HER2/NEU AMPLIFICATION IN BREAST CANCER HER2/neu Amplification in Breast Cancer Stratification by Tumor Type and Grade Elise R. Hoff, MD, Raymond R. Tubbs, DO, Jonathan L. Myles, MD,
More informationHER-2 Protein Overexpression in Metastatic Breast Carcinoma Found at Autopsy
HER-2 Protein Overexpression in Metastatic Breast Carcinoma Found at Autopsy Shigeya Kyoda 1, Satoki Kinoshita 2, Hiroshi Takeyama 1, Ken Uchida 2 and Toshiaki Morikawa 2 1 Department of Surgery, Jikei
More informationSymposium article. Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: Pivotal trial data
Annals of Oncology 12 (Suppl. I): S57-S62, 2001. 2001 Kluwer Academic Publishers. Primed in the Netherlands. Symposium article Trastuzumab combined with chemotherapy for the treatment of HER2-positive
More informationMicrocyst Formation and HIV-1 Gene Expression Occur in Multiple Nephron Segments in HIV-Associated Nephropathy
J Am Soc Nephrol 12: 2645 2651, 2001 Microcyst Formation and HIV-1 Gene Expression Occur in Multiple Nephron Segments in HIV-Associated Nephropathy MICHAEL J. ROSS, LESLIE A. BRUGGEMAN, PATRICIA D. WILSON,
More informationTubulointerstitial Renal Disease. Anna Vinnikova, MD Division of Nephrology
Tubulointerstitial Renal Disease Anna Vinnikova, MD Division of Nephrology Part I: Cystic Renal Disease www.pathguy.com Simple cysts Simple cysts May be multiple Usually 1 5cm, may be bigger Translucent,
More informationC-erbB-2 oncoprotein amplification in ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein
Malaysian.l Path01 1998; 20(1): 19-2 C-erbB-2 oncoprotein amplification in ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein Lai-Meng LOO1 FRCPath, FRCPA
More informationThe Role of HER-2 in Breast Cancer Bone Metastasis
AD Award Number: W81XWH-04-1-0627 TITLE: The Role of HER-2 in Breast Cancer Bone Metastasis PRINCIPAL INVESTIGATOR: Dihua Yu, MD, Ph.D. CONTRACTING ORGANIZATION: REPORT DATE: July 2005 University of Texas
More informationNew Treatments for ADPKD how close are we?
New Treatments for ADPKD how close are we? Leicester General Hospital 28 Jan 2012 Professor Albert Ong a.ong@sheffield.ac.uk The cystic degeneration of the kidneys, once it reaches the point where it can
More informationPrag. Polycystic kidney disease: ARPKD & ADPKD. Max Christoph Liebau
Prag Polycystic kidney disease: ARPKD & ADPKD Max Christoph Liebau Department of Pediatrics and Center for Molecular Medicine, University Hospital of Cologne Glasgow, 06th of September 2017 Cystic kidney
More informationTHE EXPRESSION OF CATHEPSIN - D, C- erb B - 2 AND EGFR IN BREAST CANCER AND ITS CORRELATION TO LYMPHATIC METASTASIS
Chinese Journal of Cancer Research 7(2) : 97-102,1995. THE EXPRESSION OF CATHEPSIN - D, C- erb B - 2 AND EGFR IN BREAST CANCER AND ITS CORRELATION TO LYMPHATIC METASTASIS Xu Liangzhong j,q: ~ qa Zhu Weiping
More information7/6/2015. Cancer Related Deaths: United States. Management of NSCLC TODAY. Emerging mutations as predictive biomarkers in lung cancer: Overview
Emerging mutations as predictive biomarkers in lung cancer: Overview Kirtee Raparia, MD Assistant Professor of Pathology Cancer Related Deaths: United States Men Lung and bronchus 28% Prostate 10% Colon
More informationFunctional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours
Britsh Journal of Cancer (1996) 74, 802-806 $0 (g 1996 Stockton Press All rights reserved 0007-0920/96 $12.00 Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overepressing
More informationRe-Purposing Drugs for the Treatment of Polycystic Kidney Disease:
Re-Purposing Drugs for the Treatment of Polycystic Kidney Disease: Partnership with the Polycystic Kidney Disease Foundation PKD Models: pcy and jck Mice, PCK Rat PreClinOmics, Inc. 1 PKDF Goals The Accelerating
More informationDelayed cystogenesis and increased ciliogenesis associated with the re-expression of polaris in Tg737 mutant mice
Kidney International, Vol. 63 (2003), pp. 1220 1229 Delayed cystogenesis and increased ciliogenesis associated with the re-expression of polaris in Tg737 mutant mice NICOLE E. BROWN and NOEL S. MURCIA
More informationPrognostic Significance of HER-2/neu Overexpression in Stage I Adenocarcinoma of Lung
Prognostic Significance of HER-2/neu Overexpression in Stage I Adenocarcinoma of Lung Chih-Cheng Hsieh, MD, Kuan-Chih Chow, PhD, Huei-Jyh Fahn, MD, Chun-Ming Tsai, MD, Wing-Yin Li, MD, Min-Hsiung Huang,
More informationAutosomal dominant polycystic kidney disease (AD-
Early Embryonic Renal Tubules of Wild-Type and Polycystic Kidney Disease Kidneys Respond to camp Stimulation with Cystic Fibrosis Transmembrane Conductance Regulator/ Na,K,2Cl Co-Transporter Dependent
More informationRenal Cystic Disease. Dr H Bierman
Renal Cystic Disease Dr H Bierman Objectives Be able to diagnose renal cystic disease Genetic / non-genetic Be able to describe patterns of various renal cystic disease on routine imaging studies Be able
More informationZenyth 340 and Benders p185 HER-2 Instant ELISA are Innovative Tools for Investigation of Cell Signalling Events Involved in Tumor Biology
Zenyth 340 and Benders p185 HER-2 Instant ELISA are Innovative Tools for Investigation of Cell Signalling Events Involved in Tumor Biology 1. Introduction The human HER-2 (c-erbb-2, neu) gene encodes a
More informationGenetics of Cancer Lecture 32 Cancer II. Prof. Bevin Engelward, MIT Biological Engineering Department
Genetics of Cancer Lecture 32 Cancer II rof. Bevin Engelward, MIT Biological Engineering Department Why Cancer Matters New Cancer Cases in 1997 Cancer Deaths in 1997 Genetics of Cancer: Today: What types
More informationReviews in Clinical Medicine
Mashhad University of Medical Sciences (MUMS) Reviews in Clinical Medicine Clinical Research Development Center Ghaem Hospital Prognostic value of HER2/neu expression in patients with prostate cancer:
More informationPolycystic kidney disease where gene dosage counts Michael R. Eccles* and Cherie A. Stayner
Published: 01 April 2014 2014 Faculty of 1000 Ltd Polycystic kidney disease where gene dosage counts Michael R. Eccles* and Cherie A. Stayner Address: Department of Pathology, Dunedin School of Medicine,
More informationkidney disease (ADPKD)
RESEARCH PROJECT MASTER BIOMEDICAL SCIENCE UNIVERSITY OF GRONINGEN The role of EGFR signaling in autosomal dominant polycystic 2016 kidney disease (ADPKD) Supervisors: Prof. Dr. H. van Goor, Prof. Dr.
More informationTITLE: The Genetic Analysis of the Role of NEU Differentiation Factor (Heregulin) in NEU-Induced Mammary Carcinomas in the Mouse
AD GRANT NO: DAMD17-94-J-4186 TITLE: The Genetic Analysis of the Role of NEU Differentiation Factor (Heregulin) in NEU-Induced Mammary Carcinomas in the Mouse PRINCIPAL INVESTIGATOR(S): Archibald S. Perkins,
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationNew insights into the molecular pathophysiology of polycystic kidney disease
Kidney International, Vol. 55 (1999), pp. 1187 1197 PERSPECTIVES IN RENAL MEDICINE New insights into the molecular pathophysiology of polycystic kidney disease NOEL S. MURCIA, WILLIAM E. SWEENEY, JR.,
More informationCHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION. Androgen deprivation therapy is the most used treatment of de novo or recurrent
CHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION Stathmin in Prostate Cancer Development and Progression Androgen deprivation therapy is the most used treatment of de novo or recurrent metastatic PCa.
More informationnumber Done by Corrected by Doctor Maha Shomaf
number 19 Done by Waseem Abo-Obeida Corrected by Abdullah Zreiqat Doctor Maha Shomaf Carcinogenesis: the molecular basis of cancer. Non-lethal genetic damage lies at the heart of carcinogenesis and leads
More informationPkd1 Inactivation Induced in Adulthood Produces Focal Cystic Disease
JASN Express. Published on September 5, 2008 as doi: 10.1681/ASN.2007101139 Pkd1 Inactivation Induced in Adulthood Produces Focal Cystic Disease Ayumi Takakura, Leah Contrino, Alexander W. Beck, and Jing
More informationCancer genetics
Cancer genetics General information about tumorogenesis. Cancer induced by viruses. The role of somatic mutations in cancer production. Oncogenes and Tumor Suppressor Genes (TSG). Hereditary cancer. 1
More informationAbnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells
Am J Physiol Renal Physiol 288: F474 F482, 2005. First published November 2, 2004; doi:10.1152/ajprenal.00227.2004. Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells
More informationGenetic Diseases Of The Kidney READ ONLINE
Genetic Diseases Of The Kidney READ ONLINE Genetic Diseases of the Kidney offers expert insight into the role of genetic abnormalities in the pathogenesis of abnormal kidney function and kidney disease.
More informationRarity of EGFR and c-erbb-2 Overexpressions in Hepatocellular Carcinoma: An Immunohistochemical Study
The Korean Journal of Pathology 2004; 38: 244-8 Rarity of EGFR and c-erbb-2 Overexpressions in Hepatocellular Carcinoma: An Immunohistochemical Study Woo Sung Moon Hyun Jin Son Ho Sung Park Min Young Park
More informationAnti-DC-SIGN/CD209 murine monoclonal antibodies
Anti-DC-SIGN/CD209 murine monoclonal antibodies DC-SIGN (DC Specific, ICAM-3 Grabbing, Nonintegrin) / CD209 and L-SIGN (liver/lymph node-specific ICAM-3-grabbing nonintegrin CD299/ DC-SIGNR (DC-SIGN-related
More informationConcise Reference. HER2 Testing in Breast Cancer. Mary Falzon, Angelica Fasolo, Michael Gandy, Luca Gianni & Stefania Zambelli
Concise Reference Testing in Breast Cancer Mary Falzon, Angelica Fasolo, Michael Gandy, Luca Gianni & Stefania Zambelli Extracted from Handbook of -Targeted Agents in Breast Cancer ublished by Springer
More informationComputational Systems Biology: Biology X
Bud Mishra Room 1002, 715 Broadway, Courant Institute, NYU, New York, USA L#5:(October-18-2010) Cancer and Signals Outline 1 2 Outline 1 2 Cancer is a disease of malfunctioning cells. Cell Lineage: Adult
More informationChinese Bulletin of Life Sciences. Over-expression of HER-2/neu and targeted therapy. CHEN Yu-ping
22 1 2010 1 Chinese Bulletin of Life Sciences Vol. 22, No. 1 Jan., 2010 1004-0374(2010)01-0069-05 HER-2/neu 100048 HER-2/neu HER- 2/neu 20%~30% P185HER2 P185HER2 (Herceptin) HER2/neu HER-2/neu P185HER2
More informationRenal injury is a third hit promoting rapid development of adult polycystic kidney disease
Renal injury is a third hit promoting rapid development of adult polycystic kidney disease Ayumi Takakura 1, Leah Contrino 1, Xiangzhi Zhou 2, Joseph V. Bonventre 1, Yanping Sun 2, Benjamin D. Humphreys
More informationJournal of Nephropathology
www.nephropathol.com DOI: 10.15171/jnp.2017.60 J Nephropathol. 2017;6(4):363-367 Journal of Nephropathology Rapidly progressive nephromegaly in a neonate with autosomal recessive poly cystic kidney disease
More informationAutosomal Dominant Polycystic Kidney Disease. Dr. Sameena Iqbal Nephrologist CIUSSS West Island
Autosomal Dominant Polycystic Kidney Disease Dr. Sameena Iqbal Nephrologist CIUSSS West Island Disclosure Honorarium for Consulting on the Reprise trial from Otsuka Mayo clinic preceptorship for PKD with
More informationNew mouse model for polycystic kidney disease with both recessive and dominant gene effects
Kidney International, VoL 47 (1995), pp. 552 558 New mouse model for polycystic kidney disease with both recessive and dominant gene effects LORRAINE FLAHERTY, ELIZABETH C. BRYDA, DORIS COLLINS, ULRICH
More informationTitle: The fate of bone marrow-derived cells carrying a polycystic kidney disease mutation in the genetically normal kidney
Author's response to reviews Title: The fate of bone marrow-derived cells carrying a polycystic kidney disease mutation in the genetically normal kidney Authors: Elizabeth Verghese (Elizabeth.Verghese@vu.edu.au)
More informationPolycystic Kidney Disease
The new england journal of medicine review article mechanisms of disease Polycystic Kidney Disease Patricia D. Wilson, Ph.D. polycystic kidney diseases are a leading cause of end-stage renal failure and
More informationPartial Nephrectomy: Does Ischemia Matter?
Partial Nephrectomy: Does Ischemia Matter? Karim Touijer, MD, MPH Attending Surgeon Memorial Sloan-Kettering Cancer Center Associate Professor of Urology Weill Cornell Medical College, New York No disclosures
More informationISPUB.COM. Prognostic And Predictive Value Of c-erbb2 Overexpression In Osteogenic Sarcoma. N Gupta, R Vasishta, N Kakkar, S Sharma INTRODUCTION
ISPUB.COM The Internet Journal of Oncology Volume 3 Number 1 Prognostic And Predictive Value Of c-erbb2 Overexpression In Osteogenic Sarcoma N Gupta, R Vasishta, N Kakkar, S Sharma Citation N Gupta, R
More informationTITLE: The Genetic Analysis of the Role of Neu Differentiation Factor (Heregulin) in Neu-Induced Mammary Carcinomas in the Mouse
. 9 4 ' AD GRANT NUMBER DAMD17-94-J-4186 TITLE: The Genetic Analysis of the Role of Neu Differentiation Factor (Heregulin) in Neu-Induced Mammary Carcinomas in the Mouse PRINCIPAL INVESTIGATOR: Archibald
More informationTHE HALLMARKS OF CANCER
THE HALLMARKS OF CANCER ONCOGENES - Most of the oncogenes were first identified in retroviruses: EGFR (ErbB), Src, Ras, Myc, PI3K and others (slightly more than 30) - Mutated cellular genes incorporated
More informationThe fate of bone marrow-derived cells carrying a polycystic kidney disease mutation in the genetically normal kidney
Verghese et al. BMC Nephrology 2012, 13:91 RESEARCH ARTICLE Open Access The fate of bone marrow-derived cells carrying a polycystic kidney disease mutation in the genetically normal kidney Elizabeth Verghese
More informationNew therapeutic prospects in autosoma dominant polycystic kidney disease
http://www.senefro.org 2008 Órgano Oficial de la Sociedad Española de Nefrología short reviews New therapeutic prospects in autosoma dominant polycystic kidney disease Roser Torra Enfermedades Renales
More informationPhospho-PRAS40 Thr246 predicts trastuzumab response in patients with HER2-positive metastatic breast cancer
ONCOLOGY LETTERS 9: 785-789, 2015 Phospho-PRAS40 Thr246 predicts trastuzumab response in patients with HER2-positive metastatic breast cancer KAI YUAN, HONGYAN WU, YULONG WANG, HONGQIANG CHEN, MINGWEN
More informationlogy The Proximal Tubule Phenotype and Its Disruption in Acute Renal Failure and Polycystic Kidney Disease
Minireview logy Exp Nephrol 1999;7:15 19 Received: April 30, 1998 Accepted: June 11, 1998 The Proximal Tubule Phenotype and Its Disruption in Acute Renal Failure and Polycystic Kidney Disease Ralph Witzgall
More informationReceiver operating characteristic (ROC) to determine cut-off points of biomarkers in lung cancer patients
Disease Markers 19 (2003,2004) 273278 273 IOS Press Receiver operating characteristic (ROC) to determine cut-off points of biomarkers in lung cancer patients Heidi L. Weiss a,, Santosh Niwas b, William
More informationEvaluation of HER2/neu oncoprotein in serum and tissue samples of women with breast cancer: Correlation with clinicopathological parameters
Evaluation of HER2/neu oncoprotein in serum and tissue samples of women with breast cancer: Correlation with clinicopathological parameters Mehdi Farzadnia, Naser TayyebiMeibodi, Fatemeh HomayiShandiz,
More informationmicrorna Therapeutics Harnessing the power of micrornas to target multiple pathways of disease
microrna Therapeutics Harnessing the power of micrornas to target multiple pathways of disease January 2018 Safe Harbor Statement Statements contained in this presentation regarding matters that are not
More informationHepato-Renal Pathology in Pkd2 ws25/ Mice, an Animal Model of Autosomal Dominant Polycystic Kidney Disease
The American Journal of Pathology, Vol. 176, No. 3, March 2010 Copyright American Society for Investigative Pathology DOI: 10.2353/ajpath.2010.090658 Gastrointestinal, Hepatobiliary and Pancreatic Pathology
More information2 nd ARPKD Family Information Day Saturday 6 th July Welcome!
2 nd ARPKD Family Information Day Saturday 6 th July 2013 Welcome! Programme - morning Welcome - Tess Harris, Chief Executive PKD Charity Overview of ARPKD and Programme Dr Larissa Kerecuk, Consultant
More informationPolycystin-1 Expression in Fetal, Adult and Autosomal Dominant Polycystic Kidney
J Korean Med Sci 2006; 21: 425-9 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Polycystin-1 Expression in Fetal, Adult and Autosomal Dominant Polycystic Kidney The mutation of the PKD1
More informationLate progression of renal pathology and cyst enlargement is reduced by rapamycin in a mouse model of nephronophthisis
original article http://www.kidney-international.org & 29 International Society of Nephrology Late progression of renal pathology and cyst enlargement is reduced by rapamycin in a mouse model of nephronophthisis
More informationNa Transport in Autosomal Recessive Polycystic Kidney Disease (ARPKD) Cyst Lining Epithelial Cells
ARTICLES J Am Soc Nephrol 14: 827 836, 2003 Na Transport in Autosomal Recessive Polycystic Kidney Disease (ARPKD) Cyst Lining Epithelial Cells RAJEEV ROHATGI,* ANDREW GREENBERG,* CHRISTOPHER R. BURROW,*
More informationINNOVAZIONI TERAPEUTICHE IN ONCOLOGIA MEDICA CAGLIARI GIUGNO 2005 Policlinico Universitario - Cagliari LAPATINIB
INNOVAZIONI TERAPEUTICHE IN ONCOLOGIA MEDICA CAGLIARI 23-24 GIUGNO 2005 Policlinico Universitario - Cagliari LAPATINIB Elena Massa CATTEDRA DI ONCOLOGIA MEDICA UNIVERSITA DEGLI STUDI DI CAGLIARI ErbB Inhibition
More informationMolecular Testing in Lung Cancer
Molecular Testing in Lung Cancer Pimpin Incharoen, M.D. Assistant Professor, Thoracic Pathology Department of Pathology, Ramathibodi Hospital Genetic alterations in lung cancer Source: Khono et al, Trans
More informationTHE HER-2/neu (c-erbb-2) proto-oncogene encodes a
Elevated Serum HER-2/neu Level Predicts Decreased Response to Hormone Therapy in Metastatic Breast Cancer By Allan Lipton, S.M. Ali, K. Leitzel, L. Demers, V. Chinchilli, L. Engle, Harold A. Harvey, C.
More informationBiomarkers of Response to EGFR-TKIs EORTC-NCI-ASCO Meeting on Molecular Markers in Cancer November 17, 2007
Biomarkers of Response to EGFR-TKIs EORTC-NCI-ASCO Meeting on Molecular Markers in Cancer November 17, 2007 Bruce E. Johnson, MD Dana-Farber Cancer Institute, Brigham and Women s Hospital, and Harvard
More informationAutosomal dominant polycystic kidney disease (AD-
A Pilot Clinical Study to Evaluate Changes in Urine Osmolality and Urine camp in Response to Acute and Chronic Water Loading in Autosomal Dominant Polycystic Kidney Disease Irina Barash,* Manish P. Ponda,*
More informationAdvanced Concept of Nursing- II UNIT-VI Advance Nursing Management of Genitourinary (GU) Diseases.
In The Name of God (A PROJECT OF NEW LIFE COLLEGE OF NURSING KARACHI) Advanced Concept of Nursing- II UNIT-VI Advance Nursing Management of Genitourinary (GU) Diseases. Shahzad Bashir RN, BScN, DCHN,MScN
More informationNephrology Dialysis Transplantation
Nephrol Dial Transplant ( 1997) 12: 2284 2288 Original Article Nephrology Dialysis Transplantation Neonatal presentation of autosomal dominant polycystic kidney disease with a maternal history of tuberous
More informationQuality in Control. ROS1 Analyte Control. Product Codes: HCL022, HCL023 and HCL024
Quality in Control ROS1 Analyte Control Product Codes: HCL022, HCL023 and HCL024 Contents What is ROS1? 2 The Role of ROS1 in Cancer 3 ROS1 Assessment 3 ROS1 Analyte Control Product Details 4 ROS1 Analyte
More informationProduct Datasheet. DARC Antibody NB Unit Size: 0.1 mg. Store at -20C. Avoid freeze-thaw cycles. Publications: 5
Product Datasheet DARC Antibody NB100-2421 Unit Size: 0.1 mg Store at -20C. Avoid freeze-thaw cycles. Publications: 5 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/nb100-2421
More informationPage 302. were taken for immunohistochemical expression of HER- of January 2017 to June 2018.Out of 105 cases, 20 cases prognosis).
ISSN- O: 2458-868X, ISSN P: 2458 8687 Index Copernicus Value: 49. 23 PubMed - National Library of Medicine - ID: 101731606 SJIF Impact Factor: 4.956 International Journal of Medical Science and Innovative
More informationSalt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance
Salt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance Matthew R. Weir, MD Professor and Director Division of Nephrology University of Maryland School of Medicine Overview Introduction Mechanisms
More informationGenetics and Cancer Ch 20
Genetics and Cancer Ch 20 Cancer is genetic Hereditary cancers Predisposition genes Ex. some forms of colon cancer Sporadic cancers ~90% of cancers Descendants of cancerous cells all cancerous (clonal)
More informationExpression and Significance of GRP78 and HER-2 in Colorectal Cancer
Expression and Significance of GRP78 and HER-2 in Colorectal Cancer Qiu-xia Ji 1, Li-li Wang 2, Lin Li 3, Xiaoming Xing 2 1 Department of Pathology, Qingdao University, Qingdao, China 2 Department of Pathology,
More informationCase 7729 Child with choledochal cyst presenting with episodes of vomitting and jaundice
Case 7729 Child with choledochal cyst presenting with episodes of vomitting and jaundice dos Santos R 1, Almeida J 1, Mendes PP 2, Pereira S 3, Borges C 3, Soares E 4. 1) Radiology resident, 2) Radiology
More informationEpithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease
Am J Physiol Renal Physiol 300: F511 F520, 2011. First published November 17, 2010; doi:10.1152/ajprenal.00038.2010. Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous
More informationAssessment of Her-2/neu Overexpression in Primary Breast Cancers and Their Metastatic Lesions: An Immunohistochemical Study
Annals o f Clinical & Laboratory Science, vol. 30, no. 3, 2000 259 Assessment of Her-2/neu Overexpression in Primary Breast Cancers and Their Metastatic Lesions: An Immunohistochemical Study Shahla Masood
More informationMacrophages Promote Cyst Growth in Polycystic Kidney Disease
Macrophages Promote Cyst Growth in Polycystic Kidney Disease Anil Karihaloo,* Farrukh Koraishy,* Sarah C. Huen,* Yashang Lee,* David Merrick, Michael J. Caplan, Stefan Somlo, and Lloyd G. Cantley* Departments
More informationSupplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of
Supplemental Figure Legends Supplemental Figure 1. Western blot analysis indicated that was detected in the fractions of plasma membrane and cytosol but not in nuclear fraction isolated from Pkd1 null
More informationCYTOKINE PROFILE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. M. Merta 1, V. Tesa? 1, T. Zima 2, M. 3irsa ~, R. Ry~,ava ~, J. Z.
Vol. 41, No. 3, March 1997 Pages 619-624 CYTOKINE PROFILE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE M. Merta 1, V. Tesa? 1, T. Zima 2, M. 3irsa ~, R. Ry~,ava ~, J. Z.abka ~ ~lst Medical Department,
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationDevelopmental Abnormalities of the Kidneys and GU System
A5 Developmental Abnormalities of the Kidneys and GU System Erin Parilla, MD Neonatologist Pediatrix Medical Group, Tampa, FL The speaker has signed a disclosure form and indicated she has no significant
More informationBiliary Atresia. Karen F. Murray, MD Professor of Pediatrics Director, Hepatobiliary Program Seattle Children s
Biliary Atresia Karen F. Murray, MD Professor of Pediatrics Director, Hepatobiliary Program Seattle Children s Biliary Atresia Incidence: 1/8,000-15,000 live births Girls > boys 1.5:1 The most common cause
More informationShort Communication. Polycystic Kidney Rat Is a Novel Animal Model of Caroli s Disease Associated with Congenital Hepatic Fibrosis
American Journal of Pathology, Vol. 158, No. 5, May 2001 Copyright American Society for Investigative Pathology Short Communication Polycystic Kidney Rat Is a Novel Animal Model of Caroli s Disease Associated
More informationThe mean AgNOR values in relation to HER-2/neu overexpression In a series of Iraqi women with breast cancer
The mean AgNOR values in relation to HER-2/neu overexpression In a series of Iraqi women with breast cancer Dr. Esraa Abdul-Aal Department of pathology and Forensic medicine Kufa College of Medicine Kufa,
More informationc-erbb-2 expression and prognosis of gastric cancer: a meta-analysis
c-erbb-2 expression and prognosis of gastric cancer: a meta-analysis Z.Q. Wang and B.J. Sun Department of Surgery, Affiliated Tongren Hospital, Shanghai Jiaotong University, Shanghai, China Corresponding
More informationMilder Presentation of Recessive Polycystic Kidney Disease Requires Presence of Amino Acid Substitution Mutations
J Am Soc Nephrol 14: 2004 2014, 2003 Milder Presentation of Recessive Polycystic Kidney Disease Requires Presence of Amino Acid Substitution Mutations LASZLO FURU*, LUIZ F. ONUCHIC, ALI GHARAVI, XIAOYING
More informationTable of Contents. 1. Overview. 2. Interpretation Guide. 3. Staining Gallery Cases Negative for CINtec PLUS
Staining Atlas Table of Contents 1. Overview 1.1 Introduction 1.2 Role of p16 INK4a 1.3 Role of Ki-67 1.4 Molecular Pathogenesis 1.5 p16 INK4a Expression in Cervical Dysplasia 1.6 The Concept of CINtec
More information